StreptAvax: IDBE said that in a dose-escalation 30-patient Phase I study, a 50 mg dose of the vaccine was safe and well tolerated in all 10 patients receiving t

ID Biomedical Corp. (IDBE; TSE:IDB), Vancouver, B.C.

Read the full 89 word article

How to gain access

Continue reading with a
two-week free trial.